Literature DB >> 20461381

Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells.

Cao Yang1, Edwin Choy, Francis J Hornicek, Kirkham B Wood, Joseph H Schwab, Xianzhe Liu, Henry Mankin, Zhenfeng Duan.   

Abstract

PURPOSE: To better understand the mechanisms of cytotoxicity and cell death induced by HDACI PCI-24781 in bone sarcoma cells.
METHODS: Four bone sarcoma cell lines were treated with PCI-24781, and the cytotoxicity was investigated. Further, accumulation of acetylated histones, p21, and PARP cleavage were evaluated in PCI-24781-treated cells. The synergistic effect of PCI-24781 to doxorubicin and its mechanism was investigated in bone sarcoma cells.
RESULTS: MTT assay demonstrated that the growth of bone sarcoma cells was inhibited after treatment with PCI-24781. Accumulation of acetylated histones, p21, and PARP cleavage were found in PCI-24781-treated cells. Expression of DNA repair protein RAD51 was inhibited, and the expression of apoptosis protein GADD45α was induced by PCI-24781 in bone sarcoma cells. Bone sarcoma cells treated with PCI-24781 become more sensitive to doxorubicin. The caspase-3/7 activity was increased with doxorubicin and PCI-24781 treatment in these cells.
CONCLUSIONS: HDACI PCI-24781 has a synergistic effect on doxorubicin-induced apoptosis in bone sarcoma cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461381     DOI: 10.1007/s00280-010-1344-7

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  25 in total

1.  A polysaccharide from Trametes robiniophila Murrill induces apoptosis through intrinsic mitochondrial pathway in human osteosarcoma (U-2 OS) cells.

Authors:  Xingkai Zhao; Shuo Ma; Ning Liu; Jiakun Liu; Wenbo Wang
Journal:  Tumour Biol       Date:  2015-02-11

Review 2.  Therapeutic applications of histone deacetylase inhibitors in sarcoma.

Authors:  Fan Tang; Edwin Choy; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Cancer Treat Rev       Date:  2017-07-06       Impact factor: 12.111

Review 3.  Epigenetic alterations in osteosarcoma: promising targets.

Authors:  Binghao Li; Zhaoming Ye
Journal:  Mol Biol Rep       Date:  2014-02-06       Impact factor: 2.316

4.  Matrine-induced autophagy counteracts cell apoptosis via the ERK signaling pathway in osteosarcoma cells.

Authors:  Kun Ma; Man-Yu Huang; Yan-Xing Guo; Guo-Qiang Hu
Journal:  Oncol Lett       Date:  2016-07-12       Impact factor: 2.967

5.  RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer.

Authors:  Wei-Ling He; Yu-Huang Li; Wei-Jian Hou; Zun-Fu Ke; Xin-Lin Chen; Li-Ya Lu; Shi-Rong Cai; Wu Song; Chang-Hua Zhang; Yu-Long He
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis and is synergistic with bortezomib in neuroblastoma.

Authors:  Giselle Saulnier Sholler; Erika A Currier; Akshita Dutta; Marni A Slavik; Sharon A Illenye; Maria Cecilia F Mendonca; Julie Dragon; Stephen S Roberts; Jeffrey P Bond
Journal:  J Cancer Ther Res       Date:  2013-12-28

7.  Inhibition of focal adhesion kinase induces apoptosis in human osteosarcoma SAOS-2 cells.

Authors:  Jialiang Wang; Jianing Zu; Gongping Xu; Wei Zhao; Yan Jinglong
Journal:  Tumour Biol       Date:  2013-10-04

8.  Matrine inhibited the growth of rat osteosarcoma UMR-108 cells by inducing apoptosis in a mitochondrial-caspase-dependent pathway.

Authors:  Feng Yan; Yang Liu; Wenbo Wang
Journal:  Tumour Biol       Date:  2013-04-16

9.  Bufalin inhibited the growth of human osteosarcoma MG-63 cells via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway.

Authors:  Dewei Wang; Zhenggang Bi
Journal:  Tumour Biol       Date:  2014-02-26

10.  Targeted therapies for bone sarcomas.

Authors:  Dominique Heymann; Françoise Rédini
Journal:  Bonekey Rep       Date:  2013-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.